Media Coverage

Quest Diagnostics announced today the formation of the Global Diagnostics Network (GDN), a partnership with other large labs across the globe for the sharing of diagnostic innovation, information, and services. The initial focus of the new partnership will include collaboration on companion diagnostics, and the creation of an emerging pathogen preparedness network to expedite infectious disease research and response. Additional initiatives are expected to be rolled out based on regional and global priorities. Quest's partners in the new network include Al Borg Medical Laboratories, founded in Saudi Arabia, with labs across the Middle East and Africa; Dasa, based in Brazil; GC Labs, based in South Korea; KingMed Diagnostics, based in Hong Kong with labs across South East Asia; Primary Health Care, based in Australia; and SynLab, based in Germany with labs across Europe and on four continents.

Soot particles from burning fossil fuels increases the risk of mouth cancer, warns new research. The first study of its kind discovered that high levels of fine particulate matter from engines, power stations and factories, and to a lesser extent, ozone, may be key. The findings, published online by the Journal of Investigative Medicine, show that the number of new cases, and deaths from, mouth cancer is increasing in many parts of the world.Study author Dr Michael McPhaul, of Quest Diagnostics in the US said: “The smaller diameter, but larger surface area, of PM2.5 means that it can be relatively easily absorbed while at the same time potentially wreaking greater havoc on the body.”

Quest Diagnostics the world's leading provider of diagnostic information services, announced today that it received the Gold Award in the 2018 Best Employers for Healthy Lifestyles awards from the National Business Group on Health (NBGH). The awards recognized 49 employers that have an exceptional commitment to improving the lives of their employees through their overall well-being, productivity and quality of life. The Gold Award is presented to member companies that have a strong commitment to holistic well-being and related metrics.

Quest Diagnostics says it is taking over lab services that had been provided by Hurley Medical Center at three locations. Quest announced the new arrangement, the financial terms of which were not disclosed, in a news release this week. Hurley spokeswoman Laura Jasso described Quest as Hurley's "transition partner in lab services" after having made the decision to close some sites where it drew blood "throughout the community."

The number of workers testing positive for drugs they’re not supposed to have is declining in South Carolina, according to a new report from the laboratory Quest Diagnostics. Still, a consistently high rate of positive drug tests has exacerbated the state’s labor shortage.

Secaucus-based Quest Diagnostics, a provider of diagnostic information services, announced that it has acquired PhenoPath, a national provider of specialized anatomic pathology (AP) and related services. Based in Seattle, PhenoPath provides AP, molecular oncology and other services that complement and extend those of the company’s Advanced Diagnostics portfolio of services. These include services, such as genetic sequencing and genomic tumor analysis, which require higher-order expertise and skill.

Gov. Phil Murphy was thrilled to join Quest Diagnostics CEO Steve Rusckowski at a ribbon-cutting for Quest’s new headquarters in Secaucus on Thursday morning. Murphy said he hoped that other CEOs would look at Quest, a Fortune 500 company, choosing New Jersey and follow suit. “We have a newfound will, in addition to our natural assets, to use our advantages to their fullest potential,” he said. “I hope that somewhere, the CEO of another forward-looking, innovative company is listening to us and saying, ‘You know what, if New Jersey works for Quest, then I’ve got to look there, too.’” Murphy spoke of the density of the talent pool in the northern region of the state, proximity to New York City, view of the city and transportation in the area. Murphy also hinted at his upcoming economic development trips abroad.

Quest Diagnostics announced today it has acquired specialized anatomic pathology service firm PhenoPath. The deal, whose terms were not disclosed, continued a buying spree for Quest this week, which included the acquisitions of Oxford Immunotec's US lab business and fertility and fertility diagnostics services firm ReproSource. PhenoPath is based in Seattle and provides anatomic pathology, molecular oncology, and other services such as genetic sequencing and genomic tumor analysis. It will operate as part of AmeriPath, a wholly owned subsidiary of Quest.

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide supply chain expertise, as well as perform laboratory reference testing.

Since Colorado legalized marijuana, the state has become a popular destination for so-called weed tourists. Johnny Welsh, a writer and bartender in Frisco, Colorado, a Rocky Mountain town near Vail, remembers when he would have the entire fall off work. "The restaurants closed, and you could travel the world," he told MoneyWatch, somewhat wistfully. Nationwide, the rate of workers testing positive for drugs has increased over the past decade, according to Quest Diagnostics, a major drug-testing laboratory. It has also risen in states that have made the drug legal. But the rate of increase has been about the same across the two categories, said Barry Sample, Quest's senior director for science and technology.